Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir
Mauro A. Garcia, Anna Farrell-Sherman, Beril Aydin, Junlin Zhuo, Emily J. Fray, Anna M. Zinsser, Jun Lai, Kirsten J. Sowers, Haoyue Li, Brianna M. Lopez, Anthony Abeyta-Lopez, Tifany Chu, Donald Lubbeck, Moonki Chae, Niklas Bachmann, , Janet D'Angelo Siliciano
The paper identifies autologous neutralizing antibodies (aNAbs) as critical determinants of HIV-1 rebound after treatment interruption, defining quantitative limits on rebound-competent reservoirs.
Proceedings of the National Academy of Sciences · Jul 2, 2026Peer-reviewedImmunology